Option chain shows key data for Sihuan Pharma Hldgs gr's stock options at various strike prices and expiration dates. Traders use this information to analyze potential trades and assess market sentiment for Sihuan Pharma Hldgs gr.

Sihuan Pharma Hldgs gr (OTC:SHPHF) Stock, Option Chain

Sihuan Pharmaceutical Holdings Group Ltd is an investment holding company. Along with its subsidiaries, the company is engaged in the research & development and the manufacture & sale of pharmaceutical products. Its portfolio comprises products for diseases related to the cardio-cerebral vascular (CCV) system, Respiratory, Neurology, and others. The group has three reportable segments: the medical aesthetic products segment including the filling, shaping, supporting, supplementing, optoelectronic device, body sculpturing, skincare, and others; the innovative medicine and other medicine segments; and the generic medicine segment which generates key revenue. Geographically, the company generates a majority of its revenue from Mainland China and the rest from the United States.

SIHUAN PHARM HOLDINGS GP by Sihuan Pharmaceutical Holdings Group Ltd.

Sihuan Pharmaceutical Holdings Group Ltd

Sihuan Pharmaceutical Holdings Group (HK:0460) has released an update. Sihuan Pharmaceutical Holdings Group Ltd. has secured an exclusive deal with...

Sihuan Pharmaceutical Secures Exclusive CartiZol Deal

Sihuan Pharmaceutical Holdings Group (HK:0460) has released an update. Sihuan Pharmaceutical announces that its subsidiary, Huisheng Biopharmaceuti...

Sihuan Pharma's New Diabetes Treatment Approved

Sihuan Pharmaceutical Holdings Group (HK:0460) has released an update. Sihuan Pharmaceutical Holdings Group Ltd. has announced that their subsidiar...

Sihuan Pharmaceutical's New Diabetes Drug Approved

Sihuan Pharmaceutical Holdings Group (HK:0460) has released an update. Sihuan Pharmaceutical Holdings Group Ltd. has announced a Board meeting sche...

Sihuan Pharma Schedules Key Board Meeting

Sihuan Pharmaceutical Holdings Group (HK:0460) has released an update. Sihuan Pharmaceutical Holdings Group Ltd. reported a 10% decrease in total r...

Sihuan Pharmaceutical Reveals Mixed Half-Year Results

Sihuan Pharmaceutical Holdings Group (HK:0460) has released an update. Sihuan Pharmaceutical Holdings Group Ltd. has announced an interim cash divi...

Sihuan Pharma Declares Mid-Year Cash Dividend

Sihuan Pharmaceutical Holdings Group (HK:0460) has released an update. Sihuan Pharmaceutical Holdings Group Ltd. has announced that its subsidiary,...

Sihuan Pharma's New Weight Loss Drug Gains Approval

Sihuan Pharmaceutical Holdings Group (HK:0460) has released an update. Sihuan Pharmaceutical Holdings Group Ltd., a leader in the Chinese medical a...

Sihuan Pharma Renews Key Contract with Hugel

Sihuan Pharmaceutical Holdings Group (HK:0460) has released an update. Sihuan Pharmaceutical Holdings Group Ltd. has announced plans to buy back sh...

Sihuan Pharmaceutical Announces Share Buyback Plan

Sihuan Pharmaceutical Holdings Group (HK:0460) has released an update. Sihuan Pharmaceutical Holdings Group has announced its plan to spin off Xuan...

Comments

Sihuan Pharma Hldgs gr

Sihuan Pharma Hldgs gr (SHPHF) Options

No option chain data available. Please try again later

Popular Channels

Tools & Features

Partners & Contributors

About Benzinga